The result is a marketing environment in which prescription drugs are promoted through testimonials, affiliate links and transformation stories that blur the line between personal experience and advertising
That reflects the type of transparent attribution that FDA's publicly stated concerns around compounded GLP-1 marketing specifically address
Right now, observes SPINS in its 2024 trend-watching report, its probably too early to say whether some of these trending foods and supplements will retain their cache if consumers hoping to see drug-like weight loss effects become disillusioned if the pounds dont fall off
Diabetes - GLP-1 agonists should be primarily considered in patients with type 2 diabetes with suboptimal glycaemic control despite maximal tolerated dose of metformin (+/- other agents) especially where weight loss is desired and/or significant stroke risk is present
WashU Medicine physicians exclusively staff Barnes-Jewish and St
His focus is on providing holistic care that addresses both the physical and emotional aspects of weight loss, empowering patients to achieve their goals with confidence and lasting results